Does aging of mesenchymal stem cells limit their potential application in clinical practice?

Aging Clinical and Experimental Research

Volumn 24, Issue 5, 2012, Pages 404-411

  Bajek, Anna ^a   Czerwinski, Mateusz ^a   Olkowska, Joanna ^a   Gurtowska, Natalia ^a   Kloskowski, Tomasz ^a   Drewa, Tomasz ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Aging research; Mesenchymal stem cells; Senescence markers

Indexed keywords

ENDOGLIN; THY 1 ANTIGEN;

ADIPOCYTE; APOPTOSIS; CELL AGING; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL THERAPY; CLINICAL TRIAL (TOPIC); DNA METHYLATION; DONOR; ELDERLY CARE; GLIA CELL; HUMAN; IN VITRO STUDY; KNEE OSTEOARTHRITIS; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; OSTEOBLAST; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TELOMERE; TISSUE REGENERATION; TREATMENT OUTCOME;

AGING; ANIMALS; ANTIOXIDANTS; CELL AGING; FEMALE; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MITOCHONDRIA; OXIDATIVE STRESS; OXYGEN; RATS; SEX FACTORS; STEROIDS;

EID: 84874621633     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.3275/8424     Document Type: Review

References (95)

1. Dai W, Hale SL, Kloner RA. Stem cell transplantation for the treatment of myocardial infraction. Transpl Immunol 2005; 15: 91-7.
2. Jackson L, Jones DR, Scotting P, Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgard Med 2009; 53: 121-6.
3. Menicanin D, Bartold PM, Zannettino A, Gronthos S. Genomic profiling of mesenchymal stem cells. Stem Cell Rev Rep 2009; 5: 36-50.
4. Shukla D, Box GN, Edwards RA, Tyson DR. Bone marrow stem cells for urologic tissue engineering. World J Urol 2008; 26: 341-9.
5. Hang Y, Lin HK, Frimberger D, Epstein RB, Kropp BP. Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int 2005; 96: 1120-5.
6. Drzewiecki BA, Thomas JC, Tanaka ST. Bone marrow-derived mesenchymal stem cells: current and future applications in the urinary bladder. Stem Cells Inter 2010: 1-5.
7. Augello A, Kurth TB, De Bari C. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 2010; 20: 121-33.
8. De Bari C, Kurth TB. Augello A. Mesenchymal stem cells from development to postnatal joint homeostasis, aging and disease. Birth Defects Res C Embryo Today 2010; 90: 257-71.
9. Garcia-Gómez I, Elvira G, Zapata AG, et al. Mesenchymal stem cells: biological properties and clinical applications. Expert Opin Biol Ther 2010; 10: 1453-68.
10. Chagastelles PC, Nardi NB, Camassola M. Biology and applications of mesenchymal stem cells. Sci Prog 2010; 93: 113-27.
11. Minguell JJ, Erice A, Conget P. Mesenchymal stem cells. Exp Biol Med 2001; 226: 507-20.
12. Suva D, Garavagila G, Menetrey J, et al. Non-hematopoietic human bone marrow contains long-lasting, pluripotential mesenchymal stem cells. J Cell Physiol 2004; 198: 110-8.
13. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. Isolation of bone marrow mesenchymal stem cells by antinerve growth factor receptor antibodies. Exp Hematol 2002; 30: 783-91.
14. Alipour R, Sadeghi F, Hashemi-Beni B, et al. Phenotypic characterizations and comparison of adult dental stem cells with adipose- derived stem cells. Int J Prev Med 2010; 1: 164-71.
15. Carlotti F, Zaldumbide A, Loomans CJ, et al. Isolated human islets contain a distinct population of mesenchymal stem cells. Islets 2010; 2: 164-73.
16. Karoubi G, Cortes-Dericts L, Breyer I, Schmid RA, Dutly AE. Identification of mesenchymal stromal cells in human lung parenchyma capable of differenting into aquaporin 5-expressing cells. Lab Invest 2009; 89: 110-14.
17. Lee HJ, Choi BH, Min BH, Park SR. Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation process in vitro. Arthiritis Rheum 2009; 60: 2325-32.
18. Majore I, Moretti P, Hass R, Kasper C. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Signal 2009; 7: 6.
19. Sanchez-Guijo FM, Blanco JF, Cruz G, et al. Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel by iliac crest aspiration from the same subjects. Cell Tissue Res 2009; 336: 501-7.
20. Salem HK, Thiemermann C. Mesenchymal stromal cells-current understanding and clinical status. Stem Cells 2010; 28: 585-96.
21. Barzilay R, Sadan O, Melamed E, Offen D. Comparative characterization of bone marrow-derived mesenchymal stromal cells from four different rat strains. Cytotherapy 2009; 11: 435-42.
22. Jones E, Yang X. Mesenchymal stem cells and bone regeneration: current status. Injury 2011; 42: 562-8.
23. Maurer MH. Proteomic definitions of mesenchymal stem cells. Stem Cells Int 2011; 704256.
24. Bunnell BA, Estes BT, Guilak F, Gimble JM. Differentiation of adipose stem cells. Methods Mol Biol 2008; 456: 155-71.
25. Chamberline G, Fox J, Ashton B, Middleton J. Concise Review: Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-49.
26. Chen Y, Shao JZ, Xiang LX, Dong HJ, Zhang GR. Mesenchymal stem cells: a promising candidates in regenerative medicine. Int J Biochem Cell Biol 2008; 40: 815-20.
27. Chiu R. Bone-marrow stem cells as a source for cell therapy. Heart Fail Rev 2003; 8: 247-51.
28. Croft AP, Przyborski SA. Mesenchymal stem cells from the bone marrow stroma: basic biology and potential for cell therapy. Curr Anaesth Crit Care 2004; 15: 410-7.
29. Xiao Y, Mareddt S, Crawford R. Clonal characterization of bone marrow derived stem cells and their application for bone regeneration. Int J Oral Sci 2010; 2: 127-35.
30. Minglian R, Bo Z, Zhengguo W. stem cells for cardiac repair: status, mechanisms, and new strategies. Stem Cells Int 2011; 2011: 310928.
31. Teven CM, Liu X, Hu N, et al. Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation. Stem Cells Int 2011; 2011: 201371.
32. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 2011; 6(4): 481-92.
33. Qing C, Wei-ding C, Wei-min F. Co-culture of chondrocytes and bone marrow mesenchymal stem cells in vitro enhances the expression of cartilaginous extracellular matrix components. Braz J Med Biol Res 2011; 44: 303-10.
34. Solchaga LA, Penick KJ, Welter JF. Chondrogenic differentiation of bone marrow-derived mesenchymal stem cells: tips and tricks. Methods Mol Biol 2011; 698: 253-78.
35. Brookes G, Cook M, Blair C, et al. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 2007; 18: 846-58.
36. Dominici M, Hofmann TJ, Horowitz EM. Bone marrow mesenchymal cells: biological properties and clinical applications. J Biol Regul Homeost Agents 2001; 15: 28-37.
37. Haynesworth SE, Baber MA, Caplan AL. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996; 166: 585-92.
38. Caplan AI. Adult Mesenchymal Stem Cells for Tissue Engineering Versus Regenerative Medicine. J Cell Physiol 2007 Nov; 213: 341-7.
39. Kassem M, Abdallah BM. Human bone-marrow-derived mesenchymal stem cells: biological characteristic and potential role in therapy of degenerative diseases. Cell Tissue Res 2008; 331: 157-63.
40. Huang XP, Sun Z, Miyagi Y, et al. Differentiation of allogenic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 2010; 122: 2419-29.
41. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371(964): 1579-86.
42. Bolland BJ, Tilley S, New AM, Dunlop DG, Oreffo RO. Adult mesenchymal stem cells and impaction grafting: a new clinical paradigm shift. Expert Rev Med Devices 2007; 4: 393-404.
43. Ortin M, Sierra J. Use of mesenchymal stem cells as treatment for graft-versus-host disease:current knowledge and controversies. Immunotherapy 2011; 3: 701-4.
44. Perez-Simon JA, Lopez-Villar O, Andreu EJ, et al. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica 2011; 96: 1072-6.
45. Sato K, Ozaki K, Mori M, Muroi K, Ozawa K. Mesenchymal stromal cells for graft-versus-host disease: basic aspects and clinical outcomes. J Clin Exp Hematop 2010; 50: 79-89.
46. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003; 121: 368-74.
47. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
48. Lepperdinger G, Brunauer R, Jamnig A, Laschober G, Kassem M. Controversial Issue: Is it safe to employ mesenchymal stem cells in cell-based therapies. Exp Gerontol 2008; 43: 1018-23.
49. Birch-Machin MA, Swalwell H. How mitochondria record the effects of UV exposure and oxidative stress using human skin as a model tissue. Mutagenesis 2010; 25: 101-7.
50. Trosko JE. Role of diet and nutrition on the alteration of the quality and quantity of stem cells in human aging and the diseases of aging. Curr Pharm Des 2008; 14: 2707-18.
51. Sethe S, Scutt A, Stolzting A. Aging of mesenchymal stem cells. Ageing Res Rev 2006; 5: 91-116.
52. Wagner W, Horn P, Castoldi M. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008; 3: e2213.
53. Wagner W, Bork S, Lepperdinger G, et al. How to track cellular aging of mesenchymal stromal cells ? Aging (Albany NY) 2010; 2: 224-30.
54. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci 1998; 95: 10614-9.
55. Dimri G P, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci 1995; 92: 9363-7.
56. Han KH, Choi HR, Won CH, et al. Alteration of the TGF-beta/ SMAD pathway in intrinsically and UV-induced skin aging. Mech Ageing Dev 2005; 126: 560-7.
57. Chen CS. Phorbol ester induces elevated oxidative activity and alkalization in a subset of lysosomes. BMC Cell Biol 2002; 3: 21.
58. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller- Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J 2003; 374: 1-20.
59. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone maroow stromal cells to support B-lymphopoiesis with age. Blood 1998; 91: 75-88.
60. Laschober GT, Brunauer R, Jamnig A, Fehrer C, Greiderer B, Lepperdinger G. Leptin receptor/CD295 is upregulated on primary human mesenchymal stem cells of advancing biological age and distinctly marks the subpopulation of dying cells. Exp Gerontol 2009; 44: 57-62.
61. Fehrer C, Voglauer R, Wieser M, et al. Techniques in gerontology: cell lines as standards for telomere length and telomerase activity assessment. Exp Gerontol 2006; 41: 648-51.
62. Graakjaer J, Christensen R, Kolyraa S, Serakinci N. Mesenchymal stem cells with high telomerase expression do not actively restore their chromosome arm specific telomere length pattern after exposure to ionizing radiation. BMC Mol Biol 2007; 8: 49.
63. Schallmoser K, Bartmann C, Rohde E, et al. Replicative senescence associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions. Haematologica 2010; 95: 867-74.
64. Pike MC, Pearce CL,Wu AH. Prevention of cancers of the breast, endometrium and ovary. Oncogene 2004; 23: 6379-91.
65. Richardson BC. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 2002; 132: 2401-5.
66. Kim J, Tavare S, Shibata D. Counting human somatic cell replicatons: Methylation mirrors endometrial stem cell divisions. Proc Natl Acad Sci U S A 2005; 102: 17739-1774.
67. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006; 7: 14.
68. Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 2004; 22: 675-82.
69. Zhou S, Greenberger JS, Epperly MW, et al. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 2008; 7: 335-43.
70. Choundhery MS, Khan M, Mahmood R, et al. Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti-apoptosis capabilities. Cell Biol Int 2012; 36: 747-53.
71. Yu JM, Wu X, Gimble JM, Guan X, Freitas MA, Bunnell BA. Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow. Aging Cell 2011; 10: 66-79.
72. Zhang W, Ou G, Hamrick M, et al. Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells. J Bone Miner Res 2008; 23: 1118-28.
73. Roura S, Farré J, Soler-Botija C, et al. Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells. Eur J Heart Fail 2006; 8: 555-63.
74. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 2001; 82: 583-90.
75. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev 2008; 129: 163-73.
76. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999; 107: 275-81.
77. Fickert S, Schröter-Bobsin U, Groß AF, et al. Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent. J Bone Miner Metab 2011; 29: 224-35.
78. Stone MD, Mihalusoya M, O'Connor CM, Prathapam R, Collins K, Zhuang X. Stepwise protein-mediated RNA folding directs assembly of telomerase ribonucleoprotein. Nature 2007; 446: 458-61.
79. Sun Y, Li W, Lu Z, et al. Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J 2011; 25: 1474-85.
80. Allsopp RC, Harley CB. Evidence for a critical telomere length in senescent human fibroblasts. Exp Cell Res 1995; 219: 130-6.
81. Smogorzewska A, de Lange T. Regualtion of telomerase by telomeric proteins. Annu Rev Biochem 2004; 73: 177-208.
82. Dhaene K, Van Marck E, Parwaresch R. Telomeres, telomerase and cancer: an up-date. Virchows Arch 200; 437: 1-16.
83. Bekaert S, Derradji H, Baatout S. Telomere biology in mammalian germ cells and during development. Dev Biol 2004; 274: 15-30.
84. Bernardo ME, Zaffaroni N, Novara F, et al. Human bone marrow- derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007; 67: 9142-9.
85. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003; 33: 919-26.
86. Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adiposetissue- derived stem cells: a case series. J Med Case Reports 2011; 5: 296.
87. Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermon M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 2004; 86-A: 1153-60.
88. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologoues mesenchymal stem cells. Pain Physician 2008; 11: 343-53.
89. Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D. Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Med Hypotheses 2008; 71): 900-8.
90. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002; 10: 199-206.
91. Kuroda R, Ishida K, Matsumoto T, et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 2007; 15: 226-31.
92. Robinson D, Ash H, Aviezer D, Agar G, Halperin N, Nevo Z. Autologous chondrocyte transplantation for reconstruction of isolated joint defects: the Assaf Harofeh experience. Isr Med Assoc J 2000; 2: 290-5.
93. Kreuz PC, Muller S, Ossendorf C, Kaps C, Erggelet C. Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: four-year clinical results. Arthrits Res Ther 2009 ;11: R33.
94. Haleem AM, Singergy AA, Sabry D, et al. The clinical use of human culture-expaded autologus bone marrow mesenchymal stem cells transplanted on plated-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage 2010; 1: 253-261.
95. Sung HJ, Hong S.C., Yoo JH, et al. Stemness evaluation of mesenchymal stem cells from placentas according to developmental stage: comparison to those from adult bone marrow. J Korean Med. Sci 2010; 25: 1418-26.